Videos
•
Why venture capital investment is vital to the growth and success of the European pharmaceuticals industry, which supports tens of millions of people every year through the development of new treatments.
Big money to invest push this acceleration and the growth of these drugs and this company.
I am Dr Rafaèle Tordjman, founder and C of jto capital a European fund private Equity Fund in healthcare and biotech. My passion is how to benefit patients in term of new drugs and accelerating this assets to new drugs.
We are targeting the Pharma demand indeed farmer are fulfilling their pipeline because of a loss of patent, it is estimated by 2030 they will lose for 300 billions of revenues because of this loss of pattern so they acquired smaller companies that we Finance at a stage of development not yet in commercialization but with very big value potential billions and it's not a bubble it's related to a value of the future projected cells these farmer are sitting on 1.7 trillions when you look at the first 25 .
First Farmer and the need is Without End two thir of the disease without treatment efficacious and uh you know even new new disase so it's without cycle without bubble always a liquidity possibility even when the market the public market are closed uh even when the micro environment is not good because you have always patient that are desperated to get new drugs an investor that should have like jto big money to invest pushes accelerate and the growth of these drugs and this company to make the maximum and the earliest way the benefit to the patient that will drive the financial performance
World Health Day: life-changing investments
Opinion
06 Apr 2023
New Invest Europe report highlights venture capital’s role in supporting pioneering European life sciences start-ups
Press releases
13 Oct 2022
The European Life Sciences Coalition (ELSC): Empowering the next generation of life-saving breakthroughs (Video)
Videos
05 Jun 2026
MEMBER ONLY
Venture capital and private equity investors’ impact on the growth and sustainability of Finnish companies
External resources
30 Sep 2025
Position Paper on Biotech & Healthcare
Positions & consultation responses
03 Nov 2025
MEMBER ONLY
Global Healthcare Private Equity Report 2024
External resources
03 Jan 2024